CRISPR/Cas9-coupled recombineering for metabolic engineering of Corynebacterium glutamicum

Metab Eng. 2017 Jul:42:157-167. doi: 10.1016/j.ymben.2017.06.010. Epub 2017 Jun 23.

Abstract

Genome engineering of Corynebacterium glutamicum, an important industrial microorganism for amino acids production, currently relies on random mutagenesis and inefficient double crossover events. Here we report a rapid genome engineering strategy to scarlessly knock out one or more genes in C. glutamicum in sequential and iterative manner. Recombinase RecT is used to incorporate synthetic single-stranded oligodeoxyribonucleotides into the genome and CRISPR/Cas9 to counter-select negative mutants. We completed the system by engineering the respective plasmids harboring CRISPR/Cas9 and RecT for efficient curing such that multiple gene targets can be done iteratively and final strains will be free of plasmids. To demonstrate the system, seven different mutants were constructed within two weeks to study the combinatorial deletion effects of three different genes on the production of γ-aminobutyric acid, an industrially relevant chemical of much interest. This genome engineering strategy will expedite metabolic engineering of C. glutamicum.

Keywords: CRISPR/Cas9; CoPaR; Corynebacterium glutamicum; Curable plasmids; Metabolic engineering; Recombineering.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CRISPR-Cas Systems*
  • Corynebacterium glutamicum* / genetics
  • Corynebacterium glutamicum* / metabolism
  • Gene Knockdown Techniques*
  • Metabolic Engineering / methods*
  • gamma-Aminobutyric Acid* / biosynthesis
  • gamma-Aminobutyric Acid* / genetics

Substances

  • gamma-Aminobutyric Acid